Serum Institute of India seeks indemnity against liabilities: Sources

Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources.

from IndiaTV: Google News Feed https://ift.tt/3vSx5Ss